The protekduo cannula for acute right ventricular support in thyrotoxicosis

Marc O Maybauer; Joseph M Brewer

doi:10.4103/aca.aca_26_23

The protekduo cannula for acute right ventricular support in thyrotoxicosis

Ann Card Anaesth. 2023 Oct-Dec;26(4):464-467. doi: 10.4103/aca.aca_26_23.

Authors

Marc O Maybauer¹, Joseph M Brewer²

Affiliations

¹ Department of Anesthesiology, Division of Critical Care Medicine, University of Florida, College of Medicine, Gainesville, FL, USA; Department of Anaesthesiology and Intensive Care Medicine, Philipps University, Marburg, Germany; Critical Care Research Group, The Prince Charles Hospital, The University of Queensland, Brisbane, Australia.
² INTEGRIS Baptist Medical Center, Nazih Zuhdi Transplant Institute, Specialty Critical Care and Acute Circulatory Support Service, Oklahoma City, OK, USA.

Abstract

A 25-year-old female was presented with acute right heart failure (aRHF) and cardiogenic shock secondary to thyrotoxicosis with concomitant acute respiratory failure. A ProtekDuo cannula was placed to provide temporary percutaneous right ventricular assistance and extracorporeal membrane oxygenation (ECMO) in venopulmonary (V-P) configuration, which provided both decompression of the right ventricle (RV) and oxygenation. With treatment of the underlying thyrotoxicosis, the RV function improved and respiratory failure resolved. She was discharged home in good condition. This case details alternative ECMO management with ProtekDuo compared to the gold standard of venoarterial (V-A) ECMO.

Keywords: ECMO; ProtekDuo; RVAD; right ventricular assist device; thyrotoxicosis; venoarterial; venopulmonary.

Publication types

Case Reports

MeSH terms

Adult
Cannula
Extracorporeal Membrane Oxygenation*
Female
Heart Failure* / complications
Heart Failure* / therapy
Heart Ventricles
Heart-Assist Devices*
Humans
Shock, Cardiogenic / therapy